Latest News
ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals, Inc. Estimates – DUS:BSFA
- ANI Pharmaceuticals launches generic duloxetine capsules
- Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
- ANI Pharmaceuticals launches generic duloxetine capsules By Investing.com
- ANI Pharmaceuticals launches generic duloxetine capsules By Investing.com
- ANI Pharmaceuticals launches generic duloxetine capsules By Investing.com
- ANI Pharmaceuticals (ANIP) President & CEO Nikhil Lalwani Sells 5,400 Shares
- Ani pharma president & ceo Lalwani sells shares for $388k
- Form 144 ANI PHARMACEUTICALS For: 16 October By Investing.com
- Ani Pharmaceuticals general counsel Cook sells $36,795 in stock By Investing.com
- Ani Pharmaceuticals SVP & CFO Stephen Carey sells $208,050 in stock
- ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP)
Headlines from the last 30 days, linking to the original publishers. See all market news →